The Benefits of R Anastomotic Technique for Billroth-II Reconstruction With Braun Anastomosis During Totally Laparoscopic Distal Gastrectomy: a Propensity Score Matching Analysis
1 other identifier
observational
246
1 country
1
Brief Summary
Between March 2019 and September 2022 in our centre, R anastomosis was performed on 123 patients undergoing TLDG for distal gastric cancer. A retrospective review of a prospectively collected database identified patients who underwent TLDG between January 2010 and September 2022. Patients who underwent R anastomosis were matched in a 1:1 ratio with patients who underwent conventional anastomosis using a propensity score based on age, sex, preoperative BMI, American Society of Anesthesiologists (ASA) score, and the history of abdominal surgery. Surgical and postoperative outcomes and clinicopathological data were analyzed for both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 5, 2024
CompletedFirst Posted
Study publicly available on registry
May 8, 2024
CompletedMay 8, 2024
May 1, 2024
3.5 years
May 5, 2024
May 5, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
the incidences of Clavien-Dindo grade II or higher
the incidences of Clavien-Dindo grade II or higher
2010-2022
anastomotic time
anastomotic time
2010-2022
Study Arms (2)
R anastomosis
B-II-B anastomosis
Interventions
Eligibility Criteria
between March 2019 and September 2022 at Northern Jiangsu people's hospital were prospectively collected, and data from patients who underwent conventional anastomosis (control group) were retrospectively collected from the same prospectively maintained database of patients who underwent TLDG between January 2010 and February 2019 at Northern Jiangsu people's hospital.
You may qualify if:
- elective surgery for endoscopic and pathological diagnosis of malignant tumour of the gastric antrum or body with no distant metastases confirmed by multilayer spiral computed tomography;
- patients who underwent B-II-B anastomosis during TLDG; and (3) patients who could be followed up postoperatively.
You may not qualify if:
- (1) patients who had received preoperative neoadjuvant radiotherapy or chemotherapy; (2) patients undergoing emergency surgery; (3) the presence of other malignant tumours concurrently; and (4) patients who were lost to follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daorong Wanglead
Study Sites (1)
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, 225001, China
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
May 5, 2024
First Posted
May 8, 2024
Study Start
March 1, 2019
Primary Completion
September 1, 2022
Study Completion
January 1, 2023
Last Updated
May 8, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share